Subjective quality of life and sexual functioning after germ-cell tumour therapy

British Journal of Cancer

Volumn 89, Issue 12, 2003, Pages 2202-2206

  Fegg, M J ^a,b   Gerl, A ^a   Vollmer, T C ^a   Gruber, U ^a   Jost, C ^a   Meiler, S ^a   Hiddemann, W ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

Germ cell tumour; Patient doctor communication; Quality of life; Sexual functioning; Testicular cancer

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; CANCER THERAPY; COGNITION; CONTROLLED STUDY; CORRELATION ANALYSIS; FUNCTIONAL DISEASE; GERM CELL TUMOR; HUMAN; LIFE SATISFACTION; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; MEDICAL LITERATURE; MULTIMODALITY CANCER THERAPY; NEOPLASM; ORCHIECTOMY; PHYSICIAN; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; PSYCHOLOGY; PSYCHOSEXUAL DISORDER; QUALITY OF LIFE; QUESTIONNAIRE; RETROPERITONEUM; SELF REPORT; SEXUAL BEHAVIOR; SEXUAL DYSFUNCTION; SEXUAL FUNCTION; SEXUALITY; SOCIAL PSYCHOLOGY; TESTIS TUMOR; TREATMENT OUTCOME;

ADULT; AGED; ANTINEOPLASTIC AGENTS; COMBINED MODALITY THERAPY; HUMANS; LYMPH NODE EXCISION; MALE; MIDDLE AGED; NEOPLASMS, GERM CELL AND EMBRYONAL; ORCHIECTOMY; PSYCHOLOGY; QUALITY OF LIFE; RETROPERITONEAL SPACE; SEXUAL BEHAVIOR; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL; TESTICULAR NEOPLASMS; TREATMENT OUTCOME;

EID: 0842308822     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6601421     Document Type: Article

References (24)

1. Bauld C, Anderson V, Arnold J (1998) Psychosocial aspects of adolescent cancer survival. J Paediatr Child Health 34(2): 120-126
2. Bohlen D, Burkhard FC, Mills R, Sonntag RW, Studer UE (2001) Fertility and sexual function following orchiectomy and 2 cycles of chemotherapy for stage I high risk nonseminomatous germ cell cancer. J Urol 165(2): 441-444
3. Bokemeyer C, Kollmannsberger C, Harstrick A, Beyer J, Gerl A, Casper J, Metzner B, Hartmann J, Schmoll H, Kanz L (1999) Treatment of patients with cisplatin-refractory testicular germ-cell cancer. German Testicular Cancer Study Group (GTCSG). Int J Cancer 83(6): 848-851
4. Bourgeois-Law G, Lotocki R (1999) Sexuality and gynaecological cancer: a needs assessment. Can J Hum Sex 8(4): 231-240
5. Calman KC (1984) Quality of life in cancer patients - an hypothesis. J Med Ethics 10: 124-127
6. Cella D (1998) Quality of life. In: Psychooncology, Holland JC (ed). pp 1135-1146. New York Oxford: Oxford University Press.
7. Che M, Tamboli P, Ro J, Park D, Ro J, Amato R, Ayala A (2002) Bilateral testicular germ cell tumors: twenty-year experience at M. D. Anderson Cancer Center. Cancer 95(6): 1228-1233
8. Flanagan J, Holmes S (2000) Social perceptions of cancer and their impacts: implications for nursing practice arising from the literature. J Adv Nurs 32(3): 740-749
9. Fossa S, Dahl A, Haaland C (1999) Health-related quality of life in patients treated for testicular cancer. Curr Opin Urol 9(5): 425-429
10. Gerl A (2000) Cisplatin-based chemotherapy of testicular cancer - two decades after a major breakthrough. Onkologie 23: 106-111
11. Greenberg D, Kornblith A, Herndon J, Zuckerman E, Schiffer C, Weiss R, Mayer R, Wolchok S, Holland J (1997) Quality of life for adult leukemia survivors treated on clinical trials of cancer and leukemia group b during the period 1971-1988: predictors for later psychologic distress. Cancer 80(10): 1936-1944
12. Hartmann J, Kuczyk M, Kollmannsberger C, Kanz L, Bokemeyer C (1999) Future prospects in the chemotherapy of metastatic nonseminomatous testicular germ-cell cancer. World J Urol 17(5): 324-333
13. Hartmann J, Nichols C, Droz J, Horwich A, Gerl A, Fossa S, Beyer J, Pont J, Einhorn L, Kanz L, Bokemeyer C (2000) The relative risk of second nongerminal malignancies in patients with extragonadal germ cell tumors. Cancer 88(11): 2629-2635
14. Hartmann U, Niccolosi A, Classer D, Gingell C, Buvat J, Moreira E, Lauman E (2002) Sexuality in patient-physician-communication. Results 'The Global Study of Sexual Attitudes and Behaviors'. Sexuologie 9(2): 50-60
15. Hawighorst-Knapstein S, Fusshoeller C, Franz C, Seufert R, Schonefuss G (2002) Quality of life before, during and after treatment for gynecologic cancer. Geburtshilfe Frauenheilkunde 62(Suppl 1): 5-8
16. Henrich G, Herschbach P (2000) Questions on Life Satisfaction (FLZ) - a short questionnaire for assessing subjective quality of life. Eur J Psychol Assess 16(3): 150-159
17. Incrocci L, Hop W, Wijnmaalen A, Slob A (2002) Treatment outcome, body image, and sexual functioning after orchiectomy and radiotherapy for Stage I-II testicular seminoma. Int J Radiat Oncol Biol Phys 53(5): 1165-1173
18. Joly F, Heron J, Kalusinski L, Bottet P, Brune D, Allouache N, Mace Lesec'h J, Couette J, Peny J, Henry Amar M (2002) Quality of life in long-term survivors of testicular cancer: a population-based case-control study. J Clin Oncol 20(1): 73-80
19. Jonker-Pool G, Van de Wiel H, Hoekstra H, Sleijfer D, Van-Driel M, Van-Basten J, Koops H (2001) Sexual functioning after treatment for testicular cancer - review and meta-analysis of 36 empirical studies between 1975-2000. Arch Sexual Behav 30(1): 55-74
20. Kunkel E, Myers R, Lartey P, Oyesanmi O (2000) Communicating effectively with the patient and family about treatment options for prostate cancer. Semin Urol Oncol 18(3): 233-240
21. Rieker P, Fitzgerald E, Kalish L (1990) Adaptive behavioral responses to potential infertility among survivors of testis cancer. J Clin Oncol 8: 347-355
22. Schmoll H (1999) Treatment of testicular tumours based on risk factors. Curr Opin Urol 9(5): 431-438
23. Strumberg D, Brugge S, Korn M, Koeppen S, Ranft J, Scheiber G, Reiners C, Mockel C, Seeber S, Scheulen M (2002) Evaluation of long-term toxicity in patients after cisplatin-based chemotherapy for non-seminomatous testicular cancer. Ann Oncol 13(2): 229-236
24. van Basten JP, Hoekstra HJ, van Driel MF, Koops HS, Droste JH, Jonker Pool G, van de Wiel HB, Sleijfer DT (1997) Sexual dysfunction in nonseminoma testicular cancer patients is related to chemotherapy-induced angiopathy. J Clin Oncol 15(6): 2442-2448